Jazz Pharmaceuticals Inc.

CA · United States · Reporting entity ID 100000005637

Total reported 2019–2025

$293.8M

#47 of 2,960 reporting companies — 0.4% of all reported industry payments

$49.2M in general payments across 225,703 records, plus $244.6M in research funding across 27,804 records.

How it breaks down

General payments $49,231,614

Research funding $244,602,034

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.